Literature DB >> 3103961

Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans.

J Timár, E Móczar, F Timár, K Pál, L Kopper, K Lapis, A Jeney.   

Abstract

The enhanced metastatic capacity of an in vivo selected Lewis lung tumor line (LLT-HH) was correlated with changes in cell-associated glycosaminoglycans (GAG) using ultrastructural cytochemistry, flow cytometry and biochemistry. The increase in highly sulphated GAG content on the cell membrane of LLT-HH cells compared to the parent LLT cells was demonstrated cytochemically. Using in vitro [3H]glucosamine labelling of GAG components it was shown that the LLT-HH cells were characterized by a high production of heparan sulphate while the parent LLT line had a high hyaluronic acid-chondroitin sulphate production. The high metastatic phenotype is accompanied by an altered production of cell-associated GAGs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103961     DOI: 10.1007/bf00116628

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  20 in total

1.  Glycosaminoglycans in the substrate adhesion sites of normal and virus-transformed murine cells.

Authors:  B J Rollins; L A Culp
Journal:  Biochemistry       Date:  1979-01-09       Impact factor: 3.162

2.  The kinetics and homogeneity of endocytosis of a receptor-bound ligand in a heterogeneous cell population studied by flow cytofluorometry.

Authors:  P Metezeau; L Djavadi-Ohaniance; M E Goldberg
Journal:  J Histochem Cytochem       Date:  1982-04       Impact factor: 2.479

3.  Analysis of developmentally homogeneous neural crest cell populations in vitro. IV. Cell proliferation and synthesis of glycosaminoglycans.

Authors:  B Glimelius; J E Pintar
Journal:  Cell Differ       Date:  1981-05

4.  Influence of collagen substrata on glycosaminoglycan production by B16 melanoma cells.

Authors:  S D Luikart; C A Maniglia; A C Sartorelli
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 5.  Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Exp Cell Res       Date:  1984-01       Impact factor: 3.905

6.  Acridine orange staining of the mammalian fibroblast cell coat.

Authors:  J Timár; G Gyapay; K Lapis
Journal:  Histochemistry       Date:  1979-11

7.  Flow cytometric measurements and electron microscopy of cell surface glycosaminoglycans using acridine orange.

Authors:  J Timar; F Boldog; L Kopper; K Lapis
Journal:  Histochem J       Date:  1985-01

8.  Glycosaminoglycan synthesis by subpopulations of epithelial cells from a mammary adenocarcinoma.

Authors:  J C Angello; K G Danielson; L W Anderson; H L Hosick
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

9.  Influence of glycosaminoglycans on endogenous DNA synthesis in isolated normal and cancer cell nuclei. Differential effect of heparin.

Authors:  K Furukawa; V P Bhavanandan
Journal:  Biochim Biophys Acta       Date:  1982-06-30

10.  Cell-cycle dependent desquamation of heparan sulfate from the cell surface.

Authors:  P M Kraemer; R A Tobey
Journal:  J Cell Biol       Date:  1972-12       Impact factor: 10.539

View more
  9 in total

1.  Demonstration of the organ preference of liver selected 'high metastatic' Lewis lung tumor cell line.

Authors:  S Paku; A Rot; A Ladányi; K Lapis
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

2.  Sulfated glycoconjugate determinants recognized by monoclonal antibody, SG-1, correlate with the experimental metastatic ability of KHT fibrosarcoma cells.

Authors:  J F Harris; D W Beaton
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

3.  Ultrastructural localization and internalization of proteoglycan epitopes in a human non-Hodgkin (B) lymphoma.

Authors:  J Timár; I Kovalszky; A Bánkfalvi; L Kopper
Journal:  Histochemistry       Date:  1990

4.  Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern.

Authors:  J Timár; I Kovalszky; S Paku; K Lapis; L Kopper
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

5.  Role of Proteoglycans in Tumor Progression.

Authors:  József Timár; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

6.  Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts.

Authors:  L Kopper; A Bankfalvi; R Mihalik; T T Glant; J Timar
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Comparative study on Lewis lung tumour lines with 'low' and 'high' metastatic capacity. III. Glycosaminoglycan synthesis, transport and degradation in cell lines.

Authors:  G Pogány; E Moczar; A Jeney; J Timár; F Timár; K Ditrói; K Lapis
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

8.  Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells.

Authors:  A Ladányi; J Tímár; K Lapis
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

9.  Galactosylated glycan expression and macrophage sensitivity of Lewis lung tumor cells with different metastatic phenotype.

Authors:  J Tímár; A Ladányi; K Lapis; E Moczar
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.